Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL740669 | 0.88 | TSHR (0.46) | TSHR | |
| SCHEMBL19885950 | 0.79 | TSHR (0.31) | TSHR | |
| SCHEMBL598853 | 0.78 | TSHR (0.46) | TSHRTDP1 | |
| SCHEMBL6983780 | 0.77 | TSHR (0.36) | TSHRTDP1 | |
| SCHEMBL11049364 | 0.77 | TSHR (0.36) | TSHR | |
| SCHEMBL9808403 | 0.77 | TSHR (0.36) | TSHR | |
| SCHEMBL4666436 | 0.72 | TSHR (0.39) | TSHR | |
| SCHEMBL28713347 | 0.72 | ALDH1A1 (0.67) | TSHR | |
| SCHEMBL10756606 | 0.69 | TSHR (0.33) | TSHRTDP1 | |
| SCHEMBL993354 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9394390-B2 | Coumarin-functionalized polyolefin and associated cyclodimerization products, preparation methods, and electronic devices | THE UNIVERSITY OF MASSACHUSETTS (US) | 2016-07-19 | — | — | US | disclosed |
| US-20150361195-A1 | COUMARIN-FUNCTIONALIZED POLYOLEFIN AND ASSOCIATED CYCLODIMERIZATION PRODUCTS, PREPARATION METHODS, AND ELECTRONIC DEVICES | THE UNIVERSITY OF MASSACHUSETTS | 2015-12-17 | — | — | US | disclosed |
| US-8765719-B2 | Therapeutic drug for adult T-cell leukemia | KAGOSHIMA UNIVERSITY (JP) | 2014-07-01 | — | — | US | disclosed |
| US-20110172185-A1 | THERAPEUTIC DRUG FOR ADULT T-CELL LEUKEMIA | KAGOSHIMA UNIVERSITY (JP) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172185-A1 | THERAPEUTIC DRUG FOR ADULT T-CELL LEUKEMIA | CBR3, CD47, ATL3 | TSHR 174/4885TDP1 2701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.